In a retrospective cohort study, anticoagulants did not protect against the significantly increased risk for venous thromboembolism resulting from the use of erythropoiesis-stimulating agents. Medscape Medical News
The American Diabetes Association and the European Association for the Study of Diabetes have updated their consensus statement, which highlights new classes of medications available. Medscape Medical News
The use of combination therapy with ACEIs or ARBs may be preferable to diuretics in hypertensive patients with high cardiovascular risk and may provide protection against end-organ damage and serious cardiovascular events, in addition to BP control. Medscape Cardiology
William H. Bestermann, Jr., MD, Medical Director, Vascular Medicine Center, Kingsport, Tennessee, explains how early diagnosis and intervention can prevent sudden coronary death. Medscape General Medicine
